General Information of the Compound
| Compound ID |
CP0434692
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(1S)-1-hydroxy-1-phenylpropyl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H39NO4
|
||||||||||||||||||
| Molecular Weight |
501.667
|
||||||||||||||||||
| Canonical SMILES |
CC[C@](O)([C@H]1C[C@]23CC[C@]1(OC)[C@@H]1Oc4c5c(C[C@H]2N(CC2CC2)CC[C@@]315)ccc4O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H39NO4/c1-3-31(35,22-7-5-4-6-8-22)24-18-29-13-14-32(24,36-2)28-30(29)15-16-33(19-20-9-10-20)25(29)17-21-11-12-23(34)27(37-28)26(21)30/h4-8,11-12,20,24-25,28,34-35H,3,9-10,13-19H2,1-2H3/t24-,25-,28-,29-,30+,31-,32-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GFFDOSHSNIMJQO-JGSIVOCFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor